文献速递腹部介入MRDSA

经导管动脉化疗栓塞术后容积功能磁共振指标变化能否预测肝细胞癌的组织病理学分级

Does the change in volumetric functional MR metrics post-TACE predict histopathologic grading of hepatocellular carcinoma?
PubMed 文献 · Eur Radiol · 2020-07-15

本回顾性研究纳入106例肝细胞癌患者共147个目标病灶,评估经导管动脉化疗栓塞(TACE)前后3个月内MRI的容积ADC(vADC)与容积静脉强化(vVE)变化能否预测组织学分级。结果显示低级别HCC的vADC、vVE及绝对vADC偏度变化中位数均高于高级别HCC,联合ΔvADC、ΔvVE及背景肝病病因鉴别高级别肿瘤的AUC达91%。作者认为ΔvADC与ΔvVE可能是HCC组织病理学分级的潜在预测指标。

要点

  • TACE术后vADC、vVE及绝对vADC偏度的变化中位数在低级别HCC中高于高级别HCC。
  • 联合ΔvADC、ΔvVE与背景肝病病因的多变量模型鉴别高级别肿瘤的AUC为91%。
  • 背景肝病病因可能是肿瘤分化程度的预测因素。

核心结论

  • TACE术后ΔvADC与ΔvVE可能是HCC组织病理学分级的潜在预测指标,联合功能MRI生物标志物与肝病病因可提高评估分化程度的准确性。

研究设计与样本

  • HIPPA合规的回顾性研究,经本机构审查委员会批准,纳入2001至2017年间106例HCC患者共147个目标病灶,均有TACE前后3个月内MRI及活检或肝移植/切除的病理报告,在基线与TACE术后MRI上测量静脉强化(VE)与表观扩散系数(ADC)的容积值,肿瘤按组织学分为低级别与高级别两组。

诊断标准与关键数值

  • TACE术后vADC、vVE与绝对vADC偏度的变化中位数在低级别HCC高于高级别HCC(分别为p < 0.001、p = 0.005、p = 0.04);多变量分析中联合ΔvADC、ΔvVE与背景肝病病因鉴别高级别肿瘤的AUC = 91%。

临床应用与阅片要点

  • 作者认为TACE术后容积功能MRI生物标志物变化可能作为无创评估HCC肿瘤组织病理学的方法,背景肝病病因可能是肿瘤分化程度的预测因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate whether the change in volumetric ADC (vADC) and volumetric venous enhancement (vVE) after transarterial chemoembolization (TACE) can predict the histologic grading of hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: This HIPPA-compliant retrospective study was approved by our institutional review board. The study population included 106 HCC patients (147 index lesions) who had MR imaging within 3 months before and after TACE and pathologic report of the HCC either by biopsy or liver transplantation/resection between 2001 and 2017. Volumetric measurements of venous enhancement (VE) and apparent diffusion coefficient (ADC) were performed on baseline and post-TACE MRI. The tumors were histologically classified into two low-grade and high-grade groups. The parameters between two groups were compared using bivariate and multivariate analyses.

RESULTS: Median change in vADC, vVE, and absolute vADC skewness after TACE was higher in low-grade HCCs as compared with high-grade HCCs (p < 0.001, p = 0.005, p = 0.04, respectively). Combining ΔvADC, ΔvVE, and the etiology for background liver disease in multivariate analysis had the highest accuracy in distinguishing high-grade tumors (AUC = 91%).

CONCLUSION: ΔvADC and ΔvVE after TACE are potential predictors of HCC histopathological grading. Combining functional MRI biomarkers with the etiology of liver disease can enhance the accuracy in assessing degree of differentiation.

KEY POINTS: • Change in volumetric functional MRI biomarkers after TACE can be a non-invasive method to evaluate tumor histopathology in HCC. • The etiology of background liver disease might be a predictor of tumor degree of differentiation.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ameli S, Shaghaghi M, Ghasabeh MA, et al. Does the change in volumetric functional MR metrics post-TACE predict histopathologic grading of hepatocellular carcinoma? Eur Radiol. 2020. PMID: 32671512. doi:10.1007/s00330-020-07052-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。